Deliver Your News to the World

CybeRelease: (OTC: ECFL) To Discuss 5-1 or 10-1 Forward Split


(CybeRelease, August 1, 2006) - Lake Harmony, PA – eCarfly, Inc. (OTC PK: ECFL announced today the company has tentatively scheduled a meeting for Friday, August 4 to discuss a possible 5-1 or 10-1 forward split. Due to the huge demand for ECFL shares and the small public float, the company will join in a meeting to discuss with their legal counsel, the possibility of a forward split. “We knew we had an amazing concept from the inception of it but we didn’t realize how well it was to be accepted by the investors and clients alike. I think at this time, the entire organization is just in awe at how many phone calls and service orders are coming in around the clock,” stated Desmond Milligan, eCarfly, Inc. CEO.

About eCarfly, Inc.:

eCarfly provides individuals and automotive dealers a hassle-free and cost-effective alternative to sell their vehicles while reducing to zero, traditional costs associated with the vehicle sales process! With the knowledge, experience, and understanding of the automotive industry, eCarfly knows exactly what works and what doesn’t. eCarfly is currently focusing on online vehicle auctions, personal watercraft auctions, and partnerships with companies such as AutoNation (NYSE: AN), CarMax, Inc. (NYSE: KMX), Asbury Automotive Group (NYSE: ABG) and private individuals interested in selling their personal vehicles.

Complete release, go to

CybeRelease Gainers are ABAXIS, Inc. (Nasdaq: ABAX), Arch Capital Group Ltd. (Nasdaq: ACGL), Applied Innovation Inc. (Nasdaq: AINN), American Superconductor Corporation (Nasdaq: AMSC), ArthroCare Corporation (Nasdaq: ARTC), Atlas America, Inc. (Nasdaq: ATLS), Beacon Power Corporation (Nasdaq: BCON) and BE Aerospace, Inc. (Nasdaq: BEAV).

CybeRelease Decliners are A.S.V., Inc. (Nasdaq: ASVI), BioScrip, Inc. (Nasdaq: BIOS), Century Aluminum Company (Nasdaq: CENX), Cholestech Corporation (Nasdaq: CTEC), DOV Pharmaceutical, Inc. (Nasdaq: DOVP), IAC/InterActiveCorp (Nasdaq: IACI), Itron, Inc. (Nasdaq: ITRI) and Intuitive Surgical, Inc. (Nasdaq: ISRG).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.